|
Shares of Gilead Sciences Inc rose as much as 3 per cent on Monday after a report said the U.S. drugmaker had been approached by Britain's AstraZeneca for a possible merger to form one of the world's largest drug companies.
AstraZeneca contacted Gilead last month, but the U.S. company, which is testing its drug remdesivir as a COVID-19 treatment, was not interested in combining with another big drugmaker, Bloomberg reported.
|